205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.38%
Revenue growth under 50% of LSCC's 4.77%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
2.44%
Gross profit growth under 50% of LSCC's 7.31%. Michael Burry would be concerned about a severe competitive disadvantage.
1.49%
EBIT growth below 50% of LSCC's 15.86%. Michael Burry would suspect deeper competitive or cost structure issues.
4.16%
Operating income growth under 50% of LSCC's 15.86%. Michael Burry would be concerned about deeper cost or sales issues.
0.83%
Net income growth under 50% of LSCC's 22.44%. Michael Burry would suspect the firm is falling well behind a key competitor.
0.96%
EPS growth under 50% of LSCC's 25.00%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
0.98%
Diluted EPS growth under 50% of LSCC's 26.67%. Michael Burry would worry about an eroding competitive position or excessive dilution.
No Data
No Data available this quarter, please select a different quarter.
-0.11%
Reduced diluted shares while LSCC is at 0.10%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
14.47%
OCF growth 1.25-1.5x LSCC's 9.74%. Bruce Berkowitz would see if superior pricing or efficient operations explain the gap.
11.93%
FCF growth similar to LSCC's 11.69%. Walter Schloss would attribute it to parallel capital spending and operational models.
66.03%
10Y revenue/share CAGR above 1.5x LSCC's 39.31%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
37.03%
5Y revenue/share CAGR above 1.5x LSCC's 2.82%. David Dodd would look for consistent product or market expansions fueling outperformance.
14.40%
3Y revenue/share CAGR at 50-75% of LSCC's 21.59%. Martin Whitman would question if the firm lags behind competitor innovations.
164.44%
10Y OCF/share CAGR above 1.5x LSCC's 47.99%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
86.38%
Below 50% of LSCC's 400.09%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
21.04%
3Y OCF/share CAGR under 50% of LSCC's 286.50%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
301.53%
Net income/share CAGR above 1.5x LSCC's 73.03% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
118.16%
Below 50% of LSCC's 290.09%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
30.19%
Below 50% of LSCC's 258.66%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
36.59%
Positive growth while LSCC is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
28.13%
5Y equity/share CAGR is in line with LSCC's 26.70%. Walter Schloss would see parallel mid-term profitability and retention policies.
21.31%
3Y equity/share CAGR at 50-75% of LSCC's 40.75%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
688.88%
Dividend/share CAGR of 688.88% while LSCC is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
167.47%
Dividend/share CAGR of 167.47% while LSCC is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
64.28%
3Y dividend/share CAGR of 64.28% while LSCC is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
3.90%
AR growth is negative/stable vs. LSCC's 11.78%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
0.38%
Inventory shrinking or stable vs. LSCC's 0.79%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
12.96%
Asset growth above 1.5x LSCC's 1.63%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
8.95%
Positive BV/share change while LSCC is negative. John Neff sees a clear edge over a competitor losing equity.
23.80%
We have some new debt while LSCC reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-0.77%
Our R&D shrinks while LSCC invests at 4.79%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-3.06%
We cut SG&A while LSCC invests at 2.60%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.